Blood pressure (DM003) | Cholesterol (DM004) | HbA1c (DM007) | ||||||||||
Target met | Target not met | Target met | Target not met | Target met | Target not met | |||||||
n | % | n | % | n | % | n | % | n | % | n | % | |
Did not participate in NDA (patients) | 885 582 | 30.4* | 357 495 | 12.3 | 882 438 | 30.3* | 360 639 | 12.4 | 750 272 | 25.8* | 492 805 | 16.9 |
Participated in NDA (patients) | 1 185 475 | 40.7 | 484 196 | 16.6 | 1 178 196 | 40.4 | 491 476 | 16.9 | 1 005 679 | 34.5 | 663 993 | 22.8 |
Total (patients) | 2 071 057 | 71.1 | 841 692 | 28.9 | 2 060 634 | 70.7 | 852 115 | 29.3 | 1 755 951 | 60.3 | 1 156 798 | 39.7 |
*Significant difference between those who did and did not participate in the NDA and who met the QOF target (p<0.0001).
HbA1c, hemoglobin A1c; NDA, National Diabetes Audit; QOF, Quality and Outcomes Framework.